Manufacturer record
Quest Laboratories Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
18 batches manufactured by Quest Laboratories Pvt. Ltd (Madhya Pradesh) were declared Not of Standard Quality between March 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
18 records linked to Quest Laboratories Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
0Banned or prohibited
0Recalled or suspended
18Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
18
NSQ batches since 2019
14
Products affected
Assay
Most common failure
Jul 2026
Latest alert
Flagged batches per year
2019 · 12020 · 12021 · 32022 · 12023 · 32024 · 22025 · 62026 · 1
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Iron n& Folic Acid Tablets I? | QT1572Mfg 2025-03 · Exp 2027-02 | The sample does not conform to claim as per IP in respect to test for DescriptionDescription | SDTL, JharkhandState lab | Jul 2026 |
| CALXIA Dicyclomine Hydrochloride Tablets IP 10 mg.. | QT0210Mfg 2024-06 · Exp 2026-05 | sample does not conform to IP with respect to the Test of Description.Description | CDL, KolkataCDSCO lab | Sep 2025 |
| ORS(Oral Rehydration Salts IP) | P0831Mfg 2024-04 · Exp 2026-03 | Uniformity of weightUniformity of weight/content | SDTL, JharkhandState lab | Jun 2025 |
| Glycical-B12 Calcium Phosphate, Vitamin D3 and Vitamin B12 Suspension | QL0606Mfg 2024-06 · Exp 2026-05 | All observations are done in Normal day light conditions with unaided eyes.18 �200 ml intact brown coloured plastic bottles received for analysis. Out of these18 �200 ml bottles, in 14 �200 ml bottles particles are stick around the neck of the bottle and cakes are distributed in the suspension and some cakes are floating on the top of the suspension. During Analysis when the content from these 14x200 ml bottles after shaking transferred individually in clean dry glass beaker, it is observed that, out of these14 � 200ml bottles, 11x200ml bottles contains white suspension with white, pale yellow, grey and black coloured cakes with some cakes floating on the top of suspension and 3x200ml bottle contain orange coloured suspension with white cakes with some cakes floating & on the top of suspension. Remaining 4x200ml bottle contains white suspension without cake and mix uniformly after shakingDescription | CDTL MumbaiCDSCO lab | Apr 2025 |
| Glycical-B12 Calcium Phosphate, Vitamin D3 and Vitamin B12 Suspension | QL0602Mfg 2024-06 · Exp 2026-05 | All observations are done in Normal day light conditions with unaided eyes.18 �200 ml intact brown coloured plastic bottles received for analysis. Out of these18 �200 ml bottles, in 5 �200 ml bottles particles are stick around the neck of the bottle and cakes are distributed in the suspension and some cakes are floating on the top of the suspension. During Analysis when the content from these 5x200 ml bottles after shaking transferred individually in clean dry glass beaker, it is observed that, all 5�200ml bottles, contains white suspension with white, pale yellow, grey and black coloured cakes with some cakes floating on the top of suspension out of remaining 13x200ml bottle 12�200ml bottle contains white suspension without cake and mixes uniformly after shaking and 1�200ml bottles contains orange coloured suspension without any cake and mix uniformly after shakingDescription | CDTL MumbaiCDSCO lab | Apr 2025 |
| Calcium & Vitamin D3 Tablets IP | QT23136Mfg 2024-11 · Exp 2026-10 | Dissolution (for Calcium) and Assay of Elemental CalciumAssay | CDL KolkataCDSCO lab | Apr 2025 |
| Calcium& Vitamin D3 Tablets IP | QT23144Mfg 2024-11 · Exp 2026-10 | Description, Dissolution (for Calcium) and Assay of Elemental CalciumAssay | CDL, KolkataCDSCO lab | Mar 2025 |
| Duloxetine Gastro-resistant Tablets IP 20 mg | T26904Mfg 2024-01 · Exp 2025-12 | Description and DissolutionDissolution | RDTL ChandigarhCDSCO lab | Dec 2024 |
| Paracetamo Paediatric Oral Suspension IP 125 mg/ml | L-0475Mfg 2022-10 · Exp 2024-09 | The Sample failed in descriptionDescription | State Lab Madhya PradeshState lab | Apr 2024 |
| Calcium and Vitamin D3 Tablets IP | T179290Mfg 2023-01 · Exp 2024-12 | Assay of Vitamin D3Assay | RDTL ChandigarhCDSCO lab | Sep 2023 |
| Calcium Citrate Tablets USP | T19386Mfg 2023-02 · Exp 2025-01 | Disintegratio n test and Assay of Calcium Citrate calculated as Elemental CalciumAssay | RDTL ChandigarhState lab | Sep 2023 |
| Calcium and Vitamin D3 Tablets IP | T179168Mfg 2022-05 · Exp 2024-04 | Assay of Vitamin D3Assay | RDTL ChandigarhCDSCO lab | Feb 2023 |
| Lomolok (Loperamide Hydrochloride Tablets I.P.) | T8842Mfg 2021-07 · Exp 2024-06 | AssayAssay | RDTL GuwahatiState lab | Dec 2022 |
| Domperidone Suspension I.P. | L6002Mfg 2019-12 · Exp 2021-11 | AssayAssay | RDTL GuwahatiState lab | Jul 2021 |
| Diclofenac Sodium Tablets IP 50 mg | T2224Mfg 2019-10 · Exp 2021-09 | DisintegrationDisintegration | CDTL MumbaiCDSCO lab | May 2021 |
| Ondansetron Tablets IP 4 mg | T13104Mfg 2020-02 · Exp 2022-01 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Mar 2021 |
| P-QUIN-2.5 (Primaquine Tablets I.P. 2.5 mg) | T1903Mfg 2018-09 · Exp 2020-08 | Assay and DissolutionAssay | RDTL GuwahatiState lab | May 2020 |
| Iron and Folic Acid Tablets | T5214Mfg 2017-06 · Exp 2019-05 | Physical Parameter, Average Weight & AssayAssay | RDTL GuwahatiState lab | Mar 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.